Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial on the Safety and Effectiveness of Subretinal Injection of NGGT001 for Treating Crystalline Retinal Degeneration

NCT06302608 is registered in ClinicalTrials.gov with Xiamen Ophthalmology Center Affiliated to Xiamen University as lead sponsor.

NCT NCT06302608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06302608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial on the Safety and Effectiveness of Subretinal Injection of NGGT001 for Treating Crystalline Retinal Degeneration
Lead sponsor
Xiamen Ophthalmology Center Affiliated to Xiamen University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
February 8, 2023
Completion date
November 25, 2028
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bietti's crystalline dystrophy